RecruitingRecruiting
The Norwegian Antirheumatic Drug Register
NCT01581294 · Diakonhjemmet Hospital
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
Long-term Safety and Effectiveness of Disease Modifying Therapies in Inflammatory Arthropathies: a Multicentre, Phase IV, Longitudinal Observational Study
About this study
This study is a modification, and an extension, of the NOR-DMARD study that was conducted in 5 Norwegian rheumatology departments in the period 2000-2012. The study includes a structured follow-up with study visits at baseline (start of biological drug) and after 3, 6, 12 months and every 12 months thereafter. Each study visit includes clinical assessment, patient-reported outcomes and measurement of acute-phase reactants. The data collection also includes blood samples for biobank at baseline and 3 months. Serious adverse events data will be systematically recorded, but other adverse events can also be retrieved by linkage to other registers.
Eligibility criteria
Inclusion Criteria:
* Age \>18 years
* Diagnosis of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, spondyloarthritis, adult juvenile idiopathic arthritis, undifferentiated arthritis, or any other inflammatory arthritis
* Clinical indication to start a new treatment with a biological disease modifying anti-rheumatic drug or a kinase inhibitor
Exclusion Criteria:
* Unwillingness or unability to give written informed consent
* Psychiatric or mental disorders, alcohol abuse or other abuse of substances, language barriers or other factors which makes adherence to the study protocol impossible
* Participation in blinded RCTs or other studies incompatible with the NOR-DMARD study protocol
Study design
Enrollment target: 15000 participants
Age groups: adult, older_adult
Timeline
Starts: 2012-04
Estimated completion: 2050-12
Last updated: 2022-08-23
Sponsor
Diakonhjemmet Hospital · other
With: University Hospital of North Norway, St. Olavs Hospital, Lillehammer Hospital for Rheumatic Diseases, Vestre Viken Hospital Trust, Helse Forde
Contacts & investigators
ContactEirik K Kristianslund, MD, PhD · contact · eirik.kristianslund@gmail.com
ContactEspen A Haavardsholm, MD, PhD · contact · e.a.haavardsholm@medisin.uio.no · +4722454086
InvestigatorTore K Kvien, MD, PhD · principal_investigator, Diakonhjemmet Hospital
All locations (6)
Vestre Viken HF Drammen HospitalCompleted
Drammen, Buskerud, Norway
Lillehammer Hospital for Rheumatic DiseasesRecruiting
Lillehammer, Oppland, Norway
Førde HospitalRecruiting
Førde, Sogn Og Fjordane, Norway
St. Olavs HospitalCompleted
Trondheim, Sør-Trøndelag, Norway
University Hospital of Northern NorwayRecruiting
Tromsø, Troms, Norway
Diakonhjemmet HospitalRecruiting
Oslo, Norway